Pramodini Medicare2026
Pramodini Medicare2026 IPO Allotment Status
The Pramodini Medicare2026 IPO allotment date is 17 Aug, finalised by registrar Purva Sharegistry (India) Pvt. Ltd.. Allotment has been finalised — check your status using the link below.
Check Pramodini Medicare2026 IPO Allotment Status ↗- →Radiology Services (MRI, CT Scan, X-Ray, Ultrasound, Mammography, DEXA Scan)
- →Clinical Pathology & Laboratory Services (Haematology, Microbiology, Immunology, Biochemistry)
- →Nuclear Medicine (PET-CT, SPECT, Nuclear Therapy)
- →24x7 Teleradiology and Remote Diagnostic Reporting
| Category | Shares | % of issue | Max allottees |
|---|---|---|---|
| Qualified Institutional Buyers (QIB) | 25,32,000 | 43.27% | — |
| Non-Institutional Investors (NII) | 9,60,000 | 16.41% | — |
| Retail Individual Investors (RII) | 20,23,200 | 34.58% | — |
| Market Maker | 3,36,000 | 5.74% | — |
- Smart Horizon Capital Advisors Pvt. Ltd.
What is the issue size and price band for the Pramodini Medicare IPO?+
The Pramodini Medicare IPO is a book-building issue worth ₹69.04 crore, consisting of a fresh issue of ₹63.14 crore and an offer for sale of ₹5.90 crore, with a price band set at ₹110 to ₹118 per equity share.
What are the key dates for subscription and listing of Pramodini Medicare IPO?+
The IPO opened for bidding on August 12, 2026, and closed on August 14, 2026. The allotment was finalized on August 17, 2026, and the shares are scheduled to list on the NSE SME platform on August 19, 2026.
What is the minimum lot size and investment required for retail investors?+
The minimum application for retail investors is 2 lots (2,400 equity shares), requiring a minimum investment of ₹2,83,200 at the upper price band of ₹118 per share.
How will the proceeds from the Pramodini Medicare IPO be utilized?+
The fresh issue proceeds will primarily be used to fund capital expenditure for purchasing medical equipment for existing and proposed diagnostic centres (₹45.15 crore) and for general corporate purposes and inorganic acquisitions (₹17.99 crore).
Who is the registrar and lead manager for the Pramodini Medicare IPO?+
Smart Horizon Capital Advisors Pvt. Ltd. is the Book Running Lead Manager, and Purva Sharegistry (India) Pvt. Ltd. acts as the registrar to the issue.
Day-wise GMP trend
| Period | Revenue | PAT | EBITDA | Net worth |
|---|---|---|---|---|
| 31 Mar 2026 | ₹63.38 Cr | ₹17.38 Cr | ₹30.90 Cr | ₹53.15 Cr |
| 31 Mar 2025 | ₹38.55 Cr | ₹11.14 Cr | ₹20.97 Cr | ₹35.77 Cr |
| 31 Mar 2024 | ₹35.79 Cr | ₹7.14 Cr | ₹15.53 Cr | ₹24.75 Cr |
| Company | EPS | NAV | P/E | RoNW |
|---|---|---|---|---|
| Dr. Lal PathLabs Ltd | — | — | 62.10 | 20.78% |
| Metropolis Healthcare Ltd | — | — | 54.30 | 12.56% |
| Krsnaa Diagnostics Ltd | — | — | 16.74 | — |